Require Substance Use Disorder inpatient providers to offer patients transportation to certain places upon discharge
Summary
HB2144 would add a new section to West Virginia law governing substance use disorder inpatient providers. The bill requires those providers to offer discharged patients transportation to a state of birth, a state where they previously lived, or a state where they have family support, with the stated goal of supporting recovery after discharge. It also directs Medicaid to seek federal approval to limit certain substance use disorder waiver services to people who have lived in West Virginia for at least six months before receiving covered services.
In addition, the bill prohibits West Virginia substance abuse inpatient providers that receive Medicaid funding from marketing to, or partnering with, out-of-state providers for the purpose of bringing individuals into West Virginia for state-covered treatment. The measure is aimed at changing how inpatient treatment providers interact with patients and how publicly funded treatment services are accessed, especially by out-of-state individuals.
Impact
If enacted, HB2144 would create new statutory duties for substance use disorder inpatient providers and new restrictions tied to Medicaid-funded treatment facilities. It would affect provider discharge practices, limit certain interstate referral or marketing arrangements, and require the state Medicaid program to pursue CMS approval before imposing a six-month residency requirement for some waiver services. The bill would therefore influence both treatment-provider operations and eligibility rules for publicly funded substance use disorder services in West Virginia.
Sentiment
Based on the bill text and available context, the overall sentiment appears to be policy-driven and protective of state treatment resources, with an emphasis on discouraging out-of-state recruitment and encouraging discharge planning that reconnects patients with support systems elsewhere. No committee transcripts or recorded votes were provided, so there is no direct evidence of support or opposition from legislative debate. The framing suggests the bill is intended to address concerns about treatment tourism and post-discharge stability.
Contention
The main points of contention are likely to be the transportation mandate, the prohibition on marketing or partnering with out-of-state providers, and the proposed residency-based eligibility limitation. Supporters would likely view these provisions as a way to reduce abuse of West Virginia-funded treatment services and improve recovery outcomes through family or home-state support. Opponents may argue that the bill could restrict access to care, interfere with patient choice, create barriers for vulnerable individuals seeking treatment, and raise federal Medicaid/CMS compliance concerns, especially regarding the proposed residency requirement.